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The melanocortin receptor 4 (MC4R) is a well-estab-
lished mediator of body weight homeostasis. How-
ever, the neurotransmitter(s) that mediate MC4R
function remain largely unknown; as a result, little is
known about the second-order neurons of the
MC4R neural pathway. Single-minded 1 (Sim1)-
expressing brain regions, which include the paraven-
tricular nucleus of hypothalamus (PVH), represent
key brain sites that mediate melanocortin action.
We conditionally restored MC4R expression in
Sim1 neurons in the background of Mc4r-null mice.
The restoration dramatically reduced obesity in
Mc4r-null mice. The anti-obesity effect was
completely reversed by selective disruption of gluta-
mate release from those same Sim1 neurons. The
reversal was caused by lower energy expenditure
and hyperphagia. Corroboratively, selective disrup-
tion of glutamate release from adult PVH neurons
led to rapid obesity development via reduced energy
expenditure and hyperphagia. Thus, this study es-
tablishes glutamate as the primary neurotransmitter
that mediates MC4Rs on Sim1 neurons in body
weight regulation.
INTRODUCTION
The obesity epidemic has imposed a major social and economic
burden on our society. As such, this epidemic demands a clear
understanding of its mechanistic cause. Over the past decades,
a large body of evidence has established the importance of the
melanocortin pathway in body weight regulation. Inactivation
of the melanocortin 4 receptor (Mc4r) gene produces massive860 Cell Metabolism 18, 860–870, December 3, 2013 ª2013 Elsevierobesity in both rodents and humans (Farooqi and O’Rahilly,
2005; Huszar et al., 1997), suggestive of underlying common
neural pathways that regulate body weight between these two
species. MC4R-expressing neurons, which mediate the effects
of a-melanocyte-stimulating hormone (a-MSH) released from
proopiomelanocortin neurons and agouti-related protein
(AgRP) released from AgRP neurons, have been directly linked
to feeding behavior and energy expenditure (Cone, 2005; Elm-
quist et al., 2005). However, although there is a well-established
role for MC4Rs in obesity development, the neurotransmitter(s)
that mediate the function of MC4Rs remain unclear, and as a
result, little is known about the second-order neurons that
mediate the function of MC4R-expressing neurons.
The paraventricular nucleus of hypothalamus (PVH) is known
to control body weight and express abundant MC4Rs and has
been identified as a major brain site of melanocortin action
(Balthasar et al., 2005). Interestingly, hypomorphism of single-
minded 1 (Sim1), a transcription factor required for PVH develop-
ment, produces obesity, and genetic deletion of Sim1 selectively
in the PVH leads to obesity (Michaud et al., 2001; Tolson et al.,
2010). Notably, while MC4Rs are broadly expressed in the brain,
selective MC4R restoration in Sim1 neurons (PVH and parts of
the amygdala) greatly rescues the obesity in Mc4r-null mice
(Balthasar et al., 2005; Kishi et al., 2003; Liu et al., 2003), sug-
gesting a major role for MC4R function in Sim1 neurons toward
body weight regulation. Consistent with the cell-type-selective
function of MC4Rs in Sim1 neurons, MC4R restoration in other
brain areas, such as hindbrain and spinal cord, showed little
effect on obesity in Mc4r-null mice (Rossi et al., 2011; Sohn
et al., 2013). Thus, despite broad expression ofMc4r in the brain,
Sim1 neurons are one key site that mediates MC4R action on
body weight regulation. Therefore, identification of the neuro-
transmitter(s) and signaling mechanisms that mediate MC4R
function in Sim1 neurons is critical to delineate the MC4R neural
pathway in body weight regulation.
The PVH contains diverse groups of neurons that use pep-
tides, glutamate, GABA, or dopamine as neurotransmittersInc.
Figure 1. Colocalization of Vglut2 andMc4r
in PVH
(A–D) Shown is Vgat (A), Vglut2 (B), and Mc4r (C)
mRNA expression by in situ hybridization in the
PVH; Vglut2, but not Vgat, is largely colocalized
with Mc4r (D). Scale bars: 50 mm. See also Fig-
ure S1.
Cell Metabolism
Glutamate Mediates MC4R Function(Cowley et al., 1999; Shi et al., 2013; Swanson and Sawchenko,
1980; Xu and Tong, 2011). Among those peptides released from
PVH neurons are corticotrophin-releasing hormone (CRH),
thyrotrophin-releasing hormone (TRH), oxytocin, and vaso-
pressin (Swanson and Sawchenko, 1980). In addition to direct
regulation of the autonomic nervous system, these peptides
also regulate distinct endocrine functions through the hypo-
thalamic pituitary axes (Swanson and Sawchenko, 1980).
Although substantial evidence supports a role for these peptides
in the regulation of energy balance (Kublaoui et al., 2008; Morton
et al., 2012; Vella et al., 2011; Zhang et al., 2011), mice with loss
of function of each of these neuropeptides exhibited few or no
defects in body weight regulation (Jacobson, 1999; Vollmer
et al., 2006; Wu et al., 2012; Yamada et al., 1997), suggesting
a possible permissive role for neuropeptides within the PVH or,
alternatively, adaptation to their developmental inactivation.
GABA and dopamine have also been implicated in the PVH
to mediate the melanocortin action and neuropeptide Y (NPY),
respectively, in energy balance regulation (Cowley et al., 1999;
Shi et al., 2013).Thus, similarly to AgRP neurons, both neuro-
petides and fast-acting neurotransmitters from PVH neurons
mediate energy balance. Interestingly, GABA and NPY released
from AgRP neurons functionally compensate for each other
in mediating AgRP neuron action in feeding (Krashes et al.,
2013). However, whether, and the extent to which, neuropep-
tides or neurotransmitters mediate MC4R action in the PVH is
unknown.
In line with this idea, we have identified that glutamate
mediates the action of MC4Rs on Sim1 neurons in body weight
regulation and that PVH neuropeptides are not capable of
compensating for loss of glutamate release from Sim1 neurons.Cell Metabolism 18, 860–870,RESULTS
MC4R-Bearing Sim1 Neurons Are
Glutamatergic
Vesicular glutamate transporter 2 (Vglut2,
also known as Slc17a6), a gene ex-
pressed in glutamatergic neurons for
loading glutamate in vesicles for presyn-
aptic release, is abundant in the hypothal-
amus (Fremeau et al., 2004; Tong et al.,
2007). To assess the extent to which
VGLUT2 (the protein encoded by Vglut2)
and MC4Rs colocalize in Sim1-express-
ing neurons, we performed RNAscope
analysis, which can detect up to three
distinct species of mRNA transcript
simultaneously (Wang et al., 2012). We
found that Vglut2 and Mc4r were abun-
dantly expressed in the PVH (Figures 1Band 1C, dashed line regions) and the nucleus of lateral olfactory
tract (NLOT; Figure S1 available online), suggesting that most
neurons in these brain regions are glutamatergic and express
Mc4r. In contrast, vesicular GABA transporter (Vgat, also known
asSlc32a1, required for loadingGABA in vesicles for presynaptic
release) was only detected in a few neurons in the PVH (Fig-
ure 1A) and rarely detected in the NLOT (Figure S1). Moreover,
Mc4r and Vglut2 signals were largely associated with each other
within a given neuron in the PVH (Figure 1D) and NLOT (Fig-
ure S1). To quantify the extent to which Mc4r and Vglut2 coloc-
alize, we chose to analyze 3 sections 20 mM thick with 120 mM
apart, ranging from bregma 0.58 mm to bregma 0.82 mm
of the mouse brain where both PVH and NLOT are located.
Counting six sections from two mice showed that roughly
98.4% ± 6.2% of MC4R-expressing neurons were positive for
Vglut2 signal, 90.2% ± 8.4% of VGLUT2-expressing neurons
were positive for Mc4r signal in the PVH, and Mc4r and Vglut2
colocalized nearly 100% in the NLOT. These results suggest
that VGLUT2, but not VGAT, is colocalized with MC4Rs in
Sim1 neurons. Thus, within Sim1 brain regions, MC4R-express-
ing neurons are largely glutamatergic, but not GABAergic.
Developmental Deletion of VGLUT2 in Sim1 Neurons
Leads to Loss of Glutamate Release and Mild Obesity
To examine the role of glutamate release from PVH neurons,
we generatedmicewith conditional excision of Vglut2 selectively
from Sim1 neurons (Sim1-Cre:Vglut2flox/flox mice). Whereas PVH
neurons in control mice showed abundant Vglut2 expression
(Figure 2A), in Sim1-Cre:Vglut2flox/flox conditional mice, Vglut2
mRNA signal was eliminated (Figure 2B inside the dashed
area). Only a small region above the third ventricle showedDecember 3, 2013 ª2013 Elsevier Inc. 861
Figure 2. Disruption of Glutamate Release
from Sim1 Neurons Affects Body Weight
(A–C) Selective deletion of Vglut2 in Sim1 neurons.
In situ hybridization against Vglut2 transcripts in
the PVH of Vglut2flox/flox mice (A) and Sim1-
Cre:Vglut2flox/flox mice (B). Vglut2 mRNA is absent
in the PVH of Sim1-Cre:Vglut2flox/flox mice, but
remains at sites immediately above the PVH
(arrows in A and B). Sim1-Cre expression is shown
by red fluorescent protein expression in Sim1-
Cre:Ai9 mice (C). The deletion pattern of Vglut2 in
the PVH is consistent with Sim1-Cre expression
pattern.
(D) KCl-induced glutamate release from PVH
sections micropunched from Vglut2flox/flox mice
and Sim1-Cre:Vglut2flox/flox mice (n = 4–5). Data
showing ratios of KCl versus base levels were
presented.
(E and F) Weekly body weight of Vglut2flox/flox and
Sim1-Cre:Vglut2flox/flox 4- to 20-week-old male
mice (n = 7–12) (E) and female mice (n = 14–15) (F).
PVH, paraventricular hypothalamus; 3V, the third
ventricle. Data are represented as mean ± SEM.
Scale bars: 100 mm. *p < 0.05, analyzed by Stu-
dent’s t test in (D) and one-way ANOVA in (E) and
(F). See also Figure S2.
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Glutamate Mediates MC4R Functionresidual signal (Figure 2B, arrows), which reflected the known
pattern of Sim1-Cre activity as indicated by robust DsRed fluo-
rescence in the PVH of Sim1-Cre:Ai9 reporter mice (Figure 2C).
In addition, the NLOT showed restricted expression of Sim1-
Cre, and in Sim1-Cre:Vglut2flox/flox mice, Vglut2 signal was elim-
inated in this region (Figure S2). Taken together, these data show
that Vglut2was selectively deleted in Sim1 neurons bySim1-Cre.
To verify that VGLUT2 deletion resulted in the loss of gluta-
mate release, we directly measured glutamate release from
micropunched PVH sections using a previously established
method (Enriori et al., 2007; Kajimoto et al., 2007). In this assay,
we used potassium chloride (KCl) to stimulate a nearly 2.5-fold
increase of glutamate release in control PVH sections, whereas
it only showed a 1.3-fold increase in PVH sections from Sim1-
Cre:Vglut2flox/flox mice (Figure 2D). The remaining 1.3-fold
increase presumably resulted from non-Sim1 glutamatergic
neurons (i.e., non-PVH tissues), which were present in the
punched PVH sections and still capable of releasing glutamate.
Together with the observed deletion of Vglut2 in the PVH (Fig-
ure 2B), these data demonstrate the efficacy of our conditional
deletion model of VGLUT2 in Sim1 neurons to probe neurotrans-
mitter function toward body weight control.
To examine the effect of deficient glutamate release fromSim1
neurons, we monitored weekly body weight in our conditional862 Cell Metabolism 18, 860–870, December 3, 2013 ª2013 Elsevier Inc.mouse models. Surprisingly, compared
to littermate controls, male Sim1-Cre:
Vglut2flox/flox mice showed mild late-
onset obesity (Figure 2E), whereas fe-
males showed no signs of abnormal
weight gain (Figure 2F). These data
suggest, at least in females, that either
glutamate release from Sim1 neurons is
not required for body weight regulationor potentially redundant and/or gender-specific pathways exist
to compensate for developmental disruption of glutamate
release in embryonic Sim1 neurons.
Deletion of VGLUT2 in Adult PVH Sim1 Neurons Leads to
Rapid Obesity Development
To address possible confounding factors associated with
disrupting glutamate release early in development, we next
conditionally deleted VGLUT2 in PVH neurons of 8- to 10-
week-old Vglut2flox/flox females through stereotaxic injection of
adeno-associated viral vectors engineered to express Cre and
GFP (AAV-Cre-GFP). Previous studies suggested that in Sim1-
Cremice, nearly all PVH neurons express Cre recombinase (Ku-
blaoui et al., 2008), and our results also verified efficient deletion
of Vglut2 in the PVH by Sim1-Cre (Figure 1). Thus, as expected,
bilateral delivery of AAV-GFP (control) (Figure 3A) or AAV-Cre-
GFP (Figure 3B) to the PVH of Vglut2flox/flox mice showed robust
targeted infection, and while Vglut2 was abundantly expressed
in the PVH with control AAV-GFP injections (Figure 3C), it was
dramatically reduced in the PVH following AAV-Cre-GFP injec-
tion (Figure 3D). The body weights of conditional knockout
mice showed a rapid increase of 13 g within 4 weeks postinjec-
tion, whereas AAV-GFP-injected controls only gained 1 g during
the same period (Figure 3E), showing the importance of
Figure 3. Bilateral Deletion of Vglut2 in Female PVH Leads to Massive Obesity
(A–D) Bilateral injections of either AAV-Cre-GFP or AAV-GFP were made in the PVH of 8- to 10-week-old Vglut2flox/flox females. GFP signal showing bilateral
delivery and expression of AAV-GFP (A) and AAV-Cre-GFP (B) shown in representative PVH sections. Vglut2 in situ signal in the PVH of Vglut2flox/flox mice that
received bilateral AAV-GFP (C) and AAV-Cre-GFP (D).
(E) Weekly body weights for a period of 7 weeks following AAV vector injections.
(F) Measurements of O2 consumption following AAV vector injection into Vglut2
flox/flox mice. Measurements were made 4 weeks postinjection. The O2 con-
sumption data were analyzed per individual animal.
(G) Accumulated food intake of AAV vector-injected Vglut2flox/flox mice measured from 2–4 weeks following injections. Data are presented as mean ± SEM; n =
4–7. *p < 0.05 and ***p < 0.001, analyzed by Student’s t tests. Scale bars: 100 mM. See also Figure S3.
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regulation. In these animals, increased body weight was associ-
ated with a significant increase in fat mass, typical of an obesity
phenotype (Figure S3). Interestingly, the observed obesity
phenotype was also accompanied by a slightly increased lean
mass (Figure S3), similar to that seen inMc4r-null mice. To eval-
uate other phenotypes following conditional loss of glutamate
release, we also monitored readouts of altered metabolism.
First, we assessed energy expenditure by measuring O2 con-
sumption at 3 weeks following AAV vector delivery. Mice with
AAV-Cre-GFP injections exhibited a significant reduction in O2
consumption as measured per individual (Figure 3F) or normal-
ized to lean mass (Figure S3). Interestingly, mice with AAV-
Cre-GFP injections also exhibited a significant reduction in
locomotion, especially during the dark period (Figure S3). Inter-
estingly, food intake measured during the same period exhibited
an initial mild and statistically insignificant increase followed by a
more pronounced and significant increase with time (Figure 3G).
This observation suggests that changes in food intake may be
secondary to increased body weight. Taken together, these
data highlight an important role for glutamate release from PVH
Sim1 neurons in regulating energy expenditure.
A Conditional Approach for Concurrent MC4R
Restoration and VGLUT2 Deletion in Sim1 Neurons
The colocalization of MC4Rs and VGLUT2 in Sim1 neurons
makes it feasible to specifically investigate the role of MC4Rs
in controlling glutamate release only from these neurons. ToCell Mdetermine if MC4Rs act cell autonomously to regulate body
weight control through glutamate release from PVH neurons,
we generated mice with restored expression of MC4Rs selec-
tively in Sim1 neurons while at the same time removing VGLUT2.
To this end, we utilized a line of knockin mice in which a DNA
fragment that harbors loxP-flanked transcription blockers (tb)
had been inserted into the endogenous promoter region of
Mc4r, referred to as Mc4rtb/tb mice. Since normal transcription
is blocked at the promoter in these mice, Mc4rtb/tb mouse
models are functionally null. However, in the presence of Cre
recombinase the floxed transcriptional blocker is excised, and
normal Mc4r expression is conditionally restored in a Cre-
dependent manner (Balthasar et al., 2005). These mice were first
crossed with Sim1-Cremice to restore MC4Rs in Sim1 neurons.
We then introduced the Vglut2flox/flox allele to eventually generate
Vglut2flox/flox, Sim1-Cre:Vglut2flox/flox, Sim1-Cre:Mc4rtb/tb,
Mc4rtb/tb, and Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox experimental
mice.
To evaluate the efficacy of our system, we first performed
Mc4r in situ hybridization against Mc4r mRNA in Sim1 neurons
of control animals. Mc4r was abundant in the PVH, NLOT, and
hindbrain (Figure S4), which was consistent with earlier reports
(Kishi et al., 2003). Moreover, confirming previous results (Balth-
asar et al., 2005),Mc4r was not detectable in any of these brain
sites of Mc4rtb/tb mice (Figure S4). Finally, in Sim1-Cre:Mc4rtb/tb
mice,Mc4rmRNA signal was strongly and selectively restored in
the PVH (Figure 3G), NLOT, and supraoptic nucleus (SON) to
levels similar to those of control mice (Figure S4). Takenetabolism 18, 860–870, December 3, 2013 ª2013 Elsevier Inc. 863
Figure 4. Glutamate Mediates MC4R Action
on Sim1Neurons in BodyWeight Regulation
(A–D) Shown are the weekly body weight mea-
surements of males (A) and their average daily
food intake measured at the age of 19–20 weeks
(n = 7–20) (B) as well as the weekly body weight of
females (C) and their average daily food intake
measured at the age of 19–20 weeks (n = 14–29)
(D). Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox mice showed
identical body weight to that of Mc4rtb/tb mice at
all time points measured in both males (A) and
females (C). Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox mice
and Mc4rtb/tb mice showed the same level of
hyperphagia as to other genotypes (B and D). All
data are presented as mean ± SEM; *p < 0.05,
one-way ANOVA test. See also Figure S4.
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can be selectively restored in Sim1 neurons in a Cre-dependent
manner. Thus, Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox mice show effi-
cient and concurrent restoration of MC4Rs and deletion of
VGLUT2 in Sim1 neurons.
Glutamate Release Mediates the Action of MC4Rs on
Sim1 Neurons in Body Weight Regulation
We monitored weekly body weight in both males and females
of five different genotypes that included Vglut2flox/flox, Sim1-
Cre:Vglut2flox/flox, Mc4rtb/tb, Sim1-Cre:Mc4rtb/tb, and Sim1-
Cre:Mc4rtb/tb:Vglut2flox/flox mice (Figures 4A and 4C). Consistent
with previous data (Balthasar et al., 2005), MC4R restoration
in Sim1 neurons (Sim1-Cre:Mc4rtb/tb mice) greatly reduced
obesity of Mc4rtb/tb mice across all time points (Figures 4A and
4C). Interestingly, in both males (Figure 4A) and females (Fig-
ure 4C), Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox mice showed body
weight identical to that of Mc4rtb/tb mice at all time points
measured, suggesting that disruption of glutamate release
from Sim1 neurons completely reversed the body weight-
rescuing effects of MC4R restoration in Sim1 neurons of Mc4r-
null mice. This effect is particularly striking in females, since
deletion of Vglut2 alone in these mice showed no defects in
body weight (Figures 1, 4A, and 4C).
To examine the mechanism underlying the body weight
phenotype, we measured daily food intake in adult mice
(20 weeks old) of all experimental genotypes. As expected,
Mc4rtb/tb mice exhibited hyperphagia, which was reduced in
both genders of Sim1-Cre:Mc4rtb/tb mice to a level comparable
to that of controls (Figures 4B and 4D). Strikingly, however,
Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox mice exhibited the same de-
gree of hyperphagia as Mc4rtb/tb mice (Figures 4B and 4D),
suggesting that disruption of glutamate release completely
reversed the reduced food consumption effects of MC4R resto-
ration in Sim1 neurons of Mc4rtb/tb mice. Taken together, these864 Cell Metabolism 18, 860–870, December 3, 2013 ª2013 Elsevier Inc.results suggest that glutamate release
mediates the body weight- and food
intake-regulating effects of MC4Rs on
Sim1 neurons.
To avoid secondary effects that might
be observed in already obese adult
Mc4rtb/tb mice (Butler and Kozak, 2010;Tscho¨p et al., 2012), we measured food intake in 3- to 4-week-
old female mice with minimal obesity development. Remarkably,
the average daily food intake was not different among genotypes
(Figure 5A). However, when measured during the same period,
both Mc4rtb/tb and Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox mice
showed a significant increase in net body weight (Figure 5B),
suggesting that the primary defect may be due to decreased
energy expenditure. Indeed, both Mc4rtb/tb mice and Sim1-
Cre:Mc4rtb/tb:Vglut2flox/flox mice showed a significant reduction
in O2 consumption at the age of 4–5 weeks, compared to control
Vglut2flox/flox mice. This finding was consistent when the O2 data
were either expressed per individual (Figure 5C) or normalized to
leanmass (Figure S5). Interestingly, we observed a higher level of
O2 consumption in Sim1-Cre:Mc4r
tb/tb, than in Mc4rtb/tb mice
(Figure 5C), arguing that the effects of body weight reduction
by MC4R restoration in Sim1 neurons of Mc4r-null mice may
be partially mediated by increased energy expenditure. Notably,
the difference in O2 consumption among genotypes is not
caused by initial body weight difference, since the starting
weights of these mice were similar when O2 consumption was
measured (Figure 5D). Similar results were also observed in
males (Figure S5), except that male Sim1-Cre:Vglut2flox/flox
mice showed reduced O2 consumption compared to control
Vglut2flox/flox mice (data not shown). In addition, the respiratory
exchange ratio, an indicator for preference in metabolizing
carbohydrate or fat, was not different during day or night periods
among genotypes (Figure S5).
Energy Expenditure Response to MTII
Whether MC4Rs on Sim1 neurons regulate energy expenditure
remains controversial (Balthasar et al., 2005; Schneider, 2009;
Skibicka and Grill, 2009). To ascertain the effect of glutamate
release from Sim1 neurons on energy expenditure, we directly
measured changes of O2 consumption in response to acute
pharmacological action of melanotan II (MTII), an MC4R agonist,
Figure 5. Effects on Food Intake and Energy
Expenditure by Disruption of Glutamate
Release in Young Mice
(A–D) Shown is the average daily food intake (A)
and net body weight increases (B) in 3- to 4-week-
old females (n = 8-21). Female O2 consumption
expressed per individual animal (C) and body
weight (D) of the same cohort of mice used for
measuring O2 consumption (n = 5–12). All data are
presented as mean ± SEM; *p < 0.05, one-way
ANOVA test. See also Figure S5.
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increased O2 consumption in control Vglut2
flox/flox mice but
had no effect inMc4rtb/tbmice (Figures 6A and 6B). Interestingly,
compared to Mc4rtb/tb mice, MTII also significantly increased
O2 consumption in Sim1-Cre:Mc4r
tb/tb mice, suggesting that
MC4Rs on Sim1 neurons promote energy expenditure (Figures
6A and 6B). Strikingly, like Mc4rtb/tb mice, Sim1-Cre:Mc4rtb/tb:
Vglut2flox/flox mice exhibited no change in energy expenditure
to MTII (Figures 6A and 6B), suggesting that disruption of gluta-
mate release reverses the effect of MC4R restoration in Sim1
neurons on energy expenditure. Consistent with data from fe-
males, similar responses in O2 consumption in response to
MTII were also observed in males (Figure 6C), except that male
Sim1-Cre:Vglut2flox/flox mice showed a significantly blunted
response in O2 consumption compared to baseline controls,
which was consistent with the mild obesity phenotype in these
mice (Figure 2).
Finally, consistent with their body weight, fat mass in Sim1-
Cre:Mc4rtb/tb:Vglut2flox/flox mice was increased to a level similar
to that of Mc4rtb/tb mice in both males and females (Figure S6).
Compared to control Vglut2flox/flox mice, fat mass in Sim1-Cre:
Vglut2flox/flox mice was significantly increased in males, but not
in females (Figure S6), which is in line with their body weight
changes (Figure 1).
Glutamate Mediates MC4R Action on Body Length
Control in Females, But Not in Males
Interestingly, in addition to the noted obesity phenotype, it
has been reported previously that Mc4r-null mice also
exhibit increased body length and associated lean mass
(Balthasar et al., 2005). Themechanism underlying the increased
body length of Mc4r-null mice is unknown. Strikingly, despite
the similar degree of obesity compared to Mc4rtb/tb mice,Cell Metabolism 18, 860–870,male Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox
mice showed no reversal in lean mass
or body length, both of which remained
at levels similar to those of Sim1-
Cre:Mc4rtb/bt mice (Figures 7A and 7C).
In striking contrast, however, female
Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox mice
showed a complete reversal and
showed levels of lean mass and body
length equivalent to those of Mc4rtb/tb
mice (Figure 7B and 7D). These data
suggest that, independent of its role
toward body weight regulation, gluta-mate mediates MC4R action on body length control in females,
but not in males.
DISCUSSION
Despite the proven importance of MC4Rs toward the develop-
ment of obesity in both rodents and humans, the neurotransmit-
ter(s) that mediate their action are not clear. As a result, the
second-order neurons that mediate the action of MC4R-
expressing neurons in this circuit are unknown. Given the broad
expression of MC4Rs throughout the brain, here we focused on
the functional role of glutamate signaling specifically from Sim1
neurons. We took interest in these cells due to their abundant
Mc4r expression, known roles in body weight control, and the
Mc4r-null obesity phenotype (Balthasar et al., 2005; Skibicka
and Grill, 2009). To specifically examine the role of glutamate
release in mediating MC4R function in Sim1 neurons, we gener-
ated a mouse model that allowed concurrent restoration of
MC4Rs while at the same time disrupting glutamate release
selectively from Sim1 neurons. This unique model allowed us
to address whether, and the extent to which, glutamate release
mediates MC4R activity on Sim1 neurons in body weight
regulation.
Consistent with previous data (Balthasar et al., 2005), the
restoration of MC4R function selectively in Sim1 neurons
reduced the obesity of Mc4r-null mice. Interestingly, the reduc-
tion of obesity by MC4R restoration was reversed by con-
comitant disruption of glutamate release from the same Sim1
neurons. The reversal was complete, and the resulting obesity
was indistinguishable from that ofMc4r-null mice. We reasoned
that this reversal was specific to MC4Rs on Sim1 neurons since
(1) MC4Rs are largely colocalized with VGLUT2 in Sim1 neurons
and (2) the reversing effect on bodyweight perfectly counters theDecember 3, 2013 ª2013 Elsevier Inc. 865
Figure 6. Effects on O2 Consumption by MTII
Injection
(A and B) Response in O2 consumption to MTII injec-
tion in females. (A) Traces of O2 consumption of five
experimental genotypes of female mice in response to
saline orMTII injection (n = 5–12). Mice (4–5weeks old)
with food removed were i.p. injected at 12:00 pm with
saline on day 1 and MTII (200 mg/mice) on day 2, fol-
lowed by measurement of O2 consumption. (B) The
increase in O2 consumption was calculated based on
changes induced by MTII relative to saline injections
for a 1.5 hr period after saline or MTII injection.
(C) Response in O2 consumption to MTII injection in
males (n = 5–9). All data are presented as mean ±
SEM; *p < 0.05, one-way ANOVA test.
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that the complete reversal of body weight by disruption of gluta-
mate release does not affect the expression of known peptides
(e.g., neuropeptides in PVH and SON neurons; data not shown),
suggesting that neuropeptides alone are not capable of
compensating for loss of glutamate release from Sim1 neurons.
This is in contrast to GABA release from AgRP neurons in which
GABA and NPY could compensate each other in mediating the
feeding behavior of AgRP neurons (Krashes et al., 2013). Thus,
we have identified glutamate as the key neurotransmitter that
mediates the action MC4Rs on Sim1 neurons in body weight
regulation. Future studies that target glutamate signaling from
these neurons should allow the identification of direct down-
stream target neurons that mediate MC4R action on Sim1 neu-
rons, as previously shown for GABA release from AgRP neurons
(Atasoy et al., 2012; Wu et al., 2009).
Together, our data from AAV-Cre-mediated VGLUT2 deletion
and from restoration of MC4Rs in Sim1 neurons demonstrate the
importance of glutamate release in body weight regulation,
which is in stark contrast to mild and gender-specific changes
in body weight that were observed when glutamate release
was disrupted early in embryonic Sim1 neurons. These results
suggest that functionally redundant pathways exist to compen-
sate for disruption of glutamate release during developmental
periods. Indeed, previous studies have shown that compensa-
tory mechanisms can effectively mask detrimental phenotypes
and perform essential physiological roles when deletion is866 Cell Metabolism 18, 860–870, December 3, 2013 ª2013 Elsevier Inc.created during developmental periods
(Luquet et al., 2005). Such plasticity in
gene compensation likely derives from the
fact that MC4Rs are widely expressed
in the brain (Kishi et al., 2003; Liu et al.,
2003) and that the action of melano-
cortin influences multiple physiological pro-
cesses, including body weight, throughout
multiple brain areas.
Given the lack of significant changes
in body weight (females) and mild obesity
(males) by disruption of glutamate release
from embryonic Sim1 neurons, we
speculate that lack of glutamate signaling
blocks the downstream pathway mediatedby MC4Rs on Sim1 neurons and invokes the pathway
mediated by MC4Rs on non-Sim1 neurons for body weight
maintenance (Figure 7E, left panel). Disruption of glutamate
release leads to mild obesity in males, but not in females, sug-
gesting that MC4R action on non-Sim1 neurons is sufficient for
body weight homeostasis in females. In mice with targeted
conditional restoration of MC4Rs in Sim1 neurons of Mc4r-null
mice, lack of MC4R function on non-Sim1 neurons does not
provide functional compensation by the melanocortin signaling.
Thus, selective disruption of glutamate release from Sim1
neurons, which blocks MC4R action in these neurons, causes
reversal of obesity to a level comparable to that of Mc4r-null
mice (Figure 7E, right panel). The location of such proposed
non-Sim1 neurons is unknown but could involve acetylcholiner-
gic neurons in the spinal cord, since restoration of MC4Rs in
these neurons increases energy expenditure and reduces
obesity (Rossi et al., 2011; Sohn et al., 2013). Nevertheless,
our results demonstrate a powerful developmental compensa-
tion within the melanocortin pathway toward regulating body
weight. These results imply that care should be taken in data
interpretation when the function of the melanocortin pathway is
examined using animal models with early embryonic loss of
gene function.
In addition to glutamate, the PVH also releases diverse
neuropeptides. Interestingly, genetic deletion of major PVH neu-
ropeptides produces little or no effects on body weight (Jacob-
son, 1999; Vollmer et al., 2006; Yamada et al., 1997), while
Figure 7. Body Length Control by Gluta-
mate Release from Sim1 Neurons and Pro-
posed Model for Glutamate in Mediating
MC4R Action on Sim1 Neurons
(A–D) Bar graphs showing lean mass in males (n =
10–22) (A) and females (n = 7–17) (B) and body
length in males (n = 10–22) (C) and females (n =
7–17) (D). Both lean mass and body length were
measured at 20 weeks of age. All data are pre-
sented as mean ± SEM; *p < 0.05, one-way
ANOVA test. See also Figure S6.
(E) A proposed model for the melanocortin action
on body weight regulation. The melanocortin
pathway regulates body weight through MC4R
expression in both Sim1 neurons and non-Sim1
neurons. Disruption of glutamate release from
Sim1 neurons blocks the action ofMC4Rs on Sim1
neurons. Left panel shows that in Sim1-Cre:
Vglut2flox/flox mice, disruption of glutamate release
from Sim1 neurons invokes activation of a
pathway mediated by MC4Rs on non-Sim1 neu-
rons (larger black arrow), which is sufficient for
body weight maintenance in females (no obesity),
but not males (mild obesity). Right panel shows
that in Sim1-Cre:Mc4rtb/tb:Vglut2flox/flox mice, only
MC4Rs on Sim1 neurons are functional and that
MC4Rs on non-Sim1 neurons are inactivated;
thus, disruption of glutamate release is incapable
of invoking activation of the pathway mediated by
MC4Rs on non-Sim1 neurons, therefore leading to
obesity comparable to that of Mc4r-null mice.
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energy balance (Parker and Bloom, 2012). Previous results
suggest a role for TRH, CRH, and oxytocin in body weight regu-
lation (Kublaoui et al., 2008; Lu et al., 2003; Vella et al., 2011;
Zhang et al., 2011). Thus, it would be highly informative to
examine whether, and the extent to which, PVH peptides
mediate MC4R action on Sim1 neurons in body weight control.
Given that our data support a role for glutamate in mediating
the body weight-regulating effects of MC4Rs on Sim1 neurons,
we speculate that PVH peptidergic action, if at all important for
body weight regulation, might be mediated by altering glutamate
release, as previously proposed for oxytocin and vasopressin
action (Bailey et al., 2006; Peters et al., 2008).
One striking observation in this study is that Mc4r-null mice
exhibit severe hyperphagia in adults, with no obvious defects
in feeding at a young age. Notably, food intake in young Mc4r-
null mice was either equivalent to or slightly greater than that
observed in controls (Albarado et al., 2004; Shaw et al., 2005;
Vella et al., 2011). Consistent with these data, deletion ofCell Metabolism 18, 860–870,MRAP2 (Mrap2/ mice), an MC4R-
interacting protein, leads to an obesity
phenotype similar to that observed in
Mc4r-null mice, with no defects in food
intake prior to obesity development
(Asai et al., 2013). In contrast, we
observed significantly reduced energy
expenditure in young Mc4r-null mice. In
addition, selective restoration of MC4Rs
in Sim1 neurons increased energy expen-diture of Mc4r-null mice, which was reversed by disruption of
glutamate release from those same neurons (Figure 4). The
changes in energy expenditure were not secondary to differ-
ences in body weight, since the starting body weights of both
experimental and control groups were comparable when energy
expenditure was measured at young ages. Thus, glutamate
mediates MC4Rs on Sim1 neurons in energy expenditure regu-
lation at young ages and, when altered, results in obesity. This
conclusion is consistent with the anatomical data that reveal
prominent projections from PVH MC4R-expressing neurons to
the brown adipose tissues (Song et al., 2008), the major thermo-
genic organ in rodents.
Our current data on food intake in adult mice, as well as previ-
ous results from pair feeding Mc4r-null mice or treating with
MC4R agonists, suggest that MC4Rs regulate food intake inde-
pendent of body weight changes (Balthasar et al., 2005; Fan
et al., 1997; Marsh et al., 1999; Ste Marie et al., 2000). In agree-
ment with this, Mrap2/ mice show both normal feeding and
normal response in feeding to MTII at a young age but ultimatelyDecember 3, 2013 ª2013 Elsevier Inc. 867
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gia in adult mice might be caused by an impaired coordination of
nutrient intake and substrate oxidation (Albarado et al., 2004;
Butler et al., 2001; Srisai et al., 2011). Collectively, our results
suggest that reduced energy expenditure in Mc4r-null mice is
responsible for initial obesity, which is acerbated by subsequent
hyperphagia. In summary, our study establishes a critical role for
glutamate in mediating the function of MC4Rs on Sim1 neurons
in the regulation of both energy expenditure and food intake.
EXPERIMENTAL PROCEDURES
Animal Care
Mice were housed at 22C–24C in a 12 hr light/12 hr dark cycle, with food and
water provided ad libitum. Animal care and procedures were approved by the
University of Texas Health Science Center at Houston Institutional Animal Care
and Use Committee.
Glutamate Release Assay
The assay for glutamate release from PVH tissues was derived from combined
methods from previous publications (Enriori et al., 2007; Kajimoto et al., 2007).
After isoflurane anesthesia, brains were taken out from Vglut2flox/flox and Sim1-
Cre: Vglut2flox/floxmice. Two slices (400 mm thick) containing PVH were treated
for 1 hr at 37Cwith artificial cerebrospinal fluid (aCSF; w/0.6 internal unit apro-
tinin/ml), which had been equilibrated with 95% O2 and 5% CO2, and then
challenged with 56 mM KCl for 1 min. Medium (50 ml) was taken from basal
and KCl-stimulated conditions for measuring glutamate concentration for an
ELISA kit.
AAV Vector Stereotaxic Injections
Both AAV-Cre-GFP and AAV-GFP vectors were purchased from the viral core
facility of the University of Pennsylvania. Either vector (20 nl) of was stereotax-
ically injected into bilateral PVH with the following coordinates: bregma
0.7 mm; midline ± 0.3 mm; dorsal surface 4.5 mm and 4.3 mm using a
0.5 ml Hamilton syringe controlled by a nanoinjector. The injection speed
was controlled at 0.5 nl/min, and the syringe was withdrawn 15 min after the
final injection.
In Situ Hybridization
RNAscope Multiplex Fluorescent Assay, one in situ hybridization (ISH) tech-
nique designed to visualize multiple cellular RNA targets in fresh frozen tissues
(Wang et al., 2012), was used for detecting the colocalization of Vgat, Vglut2,
and Mc4r in the brain (Advanced Cell Diagnostics). The digoxigenin-labeled
cRNA probes were generated against mouse Vglut2 or Mc4r mRNA, and
ISH was also performed as we previously described for validating the deletion
of Vglut2 or restoration ofMc4r mRNA in Sim1 neurons (Xu et al., 2012, 2013;
Kishi et al., 2003).
See Supplemental Information for details.
Body Weight, Food Intake, and Energy Expenditure
Weekly body weight was monitored on all genotypes fed standard mouse
chow (8664Teklad F6 Rodent Diet: 4.05 kcal/g, 3.3 kcal/g metabolizable
energy, 12.5% kcal from fat; Harlan Teklad) from 4- to 20-week-old mice.
Body composition (fat mass and lean mass) was measured at the indicated
times by using the EchoMRI system (EchoMRI). In young mice, all study sub-
jects were individually housed after weaning, and daily food intake was moni-
tored for 1 week after 3 days of acclimation. Body weights of these mice were
also recorded at the beginning and end of the measurement period. In adult
mice (19–20 weeks old), all study subjects were preacclimated for at least
1 week by single housing, and then daily food intake wasmonitored for 1 week.
Energy expenditure wasmeasured by oxygen consumption by indirect calo-
rimetry. Individually housed mice maintained on chow diet at 4–5 weeks old
were placed at room temperature (22C–24C) in chambers of a Comprehen-
sive Lab Animal Monitoring System (CLAMS; Columbus Instruments). Food
and water were provided ad libitum. Mice were acclimatized in the chambers
for at least 48 hr prior to data collection.868 Cell Metabolism 18, 860–870, December 3, 2013 ª2013 ElsevierMTII Action on Energy Expenditure
Mice, at 4–5 weeks old, were acclimated in CLAMS chambers for at least
2 days. As previously described (Balthasar et al., 2005), all mice were intraper-
itoneally (i.p.) injected with normal saline at 12:00 pm on day 1; their food was
removed and theO2 consumptionwasmeasured for the ensuing 2 hr.Onday 2,
all mice were i.p. injected with 200 mgMTII (H3902; Bachem) at 12:00 pm, their
food was removed, and O2 consumption was monitored for the ensuing 2 hr.
Statistical Analysis
Data represent means ± SEM. Statistical analysis was performed using
GraphPad Prism. Statistical significance among the groups was tested using
one-way ANOVA followed by a post hoc least significant difference test or
an unpaired Student’s t test, when appropriate. Statistical significance was
defined as p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cmet.2013.11.003.
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